19 June 2013
Keywords: celgene, submits, ind, new, form, adhd, drug
Article | 13 January 1997
- Celgene Corp has submitted an Investigational New Drug Applicationwith the US Food and Drug Administration to begin Phase I/II ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
There are no related articles.
© 2013 thepharmaletter.com